Connect with us

Technology

ixlayer and Ipsos’ “ixInsights 2025” Study Reveals Consumer Expectations for Digital Health and Pharma’s Role in Enhancing Patient Experience

Published

on

Study Captures Drivers and Deterrents to Digital Health to Inform Biopharma Cx, Commercialization and Marketing Efforts

SAN FRANCISCO, April 1, 2025 /PRNewswire/ — ixlayer, a leading cloud-based healthtech platform, with Ipsos, a global leader in market research, have released findings from the inaugural research report, “ixlayer ixInsights 2025: Pharma’s Role in Improving the Health Experience.” The study looks at patients with specific conditions–asthma, COPD, type 2 diabetes, heart disease, psoriasis, or atopic dermatitis–to identify their experiences, motivations and barriers to digital health adoption. More importantly, it looks ahead outlining actionable insight and drivers to enhance biopharma’s customer experience (Cx), commercialization and marketing efforts.

To view the complete “ixlayer ixInsights 2025” study by Ipsos, email contact@ixlayer.com to request a copy.

A resounding 74% of surveyed patients would value help from a pharmaceutical company to reduce their healthcare barriers. These findings explore the health solutions these patients are looking for and the positive impact on the perception of the pharma companies that offer them.

In fact, 8 in 10 patients in this survey said that pharmaceutical companies should provide resources to help them get the care and medicines they need (81%). The report highlights consumers’ strong demand for various digital health solutions from pharma including patient assistance, affordability, easier access to lab testing, tools to help access medication and telehealth services. Consumer sentiment aligns with the 83% of U.S. physicians across specialties that believe at-home diagnostic tests help move patients through the care continuum faster, leading to earlier diagnosis and treatment to support better health, according to a separate 2024 survey of U.S. physicians.

“The expansion of DTC initiatives and services leveraging digital technology for pharma is a hot topic among the biopharma leaders we meet with, and partnering with Ipsos allowed us to uncover the real challenges and opportunities shaping the future of this emerging model,” explained Pouria Sanae, co-founder and CEO, ixlayer. “This survey confirms that patients don’t just want treatment from pharma—they want seamless, digital-first healthcare experiences that fit into their lives.”

“It is crucial for all stakeholders to focus on integrating and developing tools that put patients at the core,” explained Chareen Lim, SVP of Ipsos Healthcare. “The journey towards a seamless patient experience is ongoing, and this study shows there are ample opportunities to innovate and improve within this young and dynamic sector.”

Excerpted data: “ixlayer ixInsights 2025: Pharma’s Role in Improving the Health Experience”

Current adoption is strong, with room for technical improvementsMore than 3 out of 4 respondents agree that digital health solutions have helped maintain better communication with their healthcare providers (77%)They believe that it’s a cost effective way to maintain their health (73%)27% report having technical difficulties when using digital health solutions50% have to use multiple digital health platformsTop digital health solutions 92% of surveyed patients use or have used patient portals for accessing healthcare information and resources82% use or have used telehealth platforms for virtual consultations67% use or have used pharmacy delivery services65% use or have used wearable devices for health62% use or have used at-home diagnostic testing kitsThese patients want pharma to do more 81% of respondents believe pharmaceutical companies should provide resources to help them access care and medicationsOnly 16% strongly believes pharma prioritizes their needsAttributes of digital health services poised to drive usageAbility to consult with healthcare professionals virtually or schedule in person83% of respondents report a likelihood to useAccept insurance coverage for services83% report a likelihood to useSecure options for sharing your health data (e.g., lab test results) with others including your healthcare provider79% report a likelihood to useEasier access for lab testing, at-home kits, or scheduling at service center78% report a likelihood to useProvides digital pharmacy options (e.g., online ordering, prescription delivery)74% report a likelihood to use92% of surveyed patients say their perception of pharma would improve if they offered at least one of the following digital health solutions, including:Ability to consult with healthcare professionals virtually or schedule in person78% say it would improve their perception of pharmaAccept insurance coverage for services83% say it would improve their perception of pharmaSecure options for sharing your health data (e.g., lab test results) with others including your healthcare provider77% say it would improve their perception of pharmaEasier access for lab testing, at-home kits, or scheduling at service center78% say it would improve their perception of pharmaProvides digital pharmacy options (e.g., online ordering, prescription delivery)74% say it would improve their perception of pharma

The study captures consumer sentiment for what’s working and what’s not in digital health. Their top reasons for satisfaction with digital health are: convenience, improved communication with healthcare providers, quicker access to treatment or care, and easier access to the medications they need. The top reasons for dissatisfaction with digital health are: the need to use multiple platforms to get what they need, technical issues, and concerns about data security.

The rise of digital health, telemedicine, and direct-to-patient platforms highlights the growing demand for technology-driven healthcare solutions. As consumers increasingly expect these innovations, the survey findings signal a critical opportunity for pharma to strengthen its relationship with patients. Companies that prioritize patient-centric, digital solutions will be well-positioned to lead in the evolving healthcare ecosystem.

About ixlayer

ixlayer [pronounced: I-X-layer] is the leading provider of cloud-based platforms that power a seamless, end-to-end direct-to-patient healthcare experience. The name reflects our core strength: “i” for robust data and technology infrastructure and “x” for exceptional user experience. ixEngage by ixlayer seamlessly integrates with all healthcare ecosystem partners, connecting biopharma with patients in a user-centric way. This proprietary technology accelerates the path to diagnoses, supports optimal care, drives operational efficiency, and improves health equity and outcomes for all. To date, ixlayer has activated over four million patient care journeys, simplifying the complex web of healthcare. Learn more at www.ixlayer.com.

About Ipsos

Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing over 18,000 people.

Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.

Our tagline “Game Changers” sums up our ambition to help our 5,000 customers move confidently through a rapidly changing world.

Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120 and Mid-60 indices and is eligible for the Deferred Settlement Service (SRD). ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP www.ipsos.com

Survey Methodology
These are some of the findings of an ixlayer patient survey, with data collection done by Ipsos. A total of n=414 individuals, ages 21+, with at least one of the following conditions was surveyed online between January 6-24, 2025: asthma, COPD, type 2 diabetes, heart disease, psoriasis, or atopic dermatitis. Some quotas were placed around respondent age in order to achieve a nearly even split of baby boomer, Gen X, and millennial respondents. No weights were applied to the data, and the findings reflect the opinion of these survey respondents only. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ixlayer-and-ipsos-ixinsights-2025-study-reveals-consumer-expectations-for-digital-health-and-pharmas-role-in-enhancing-patient-experience-302416443.html

SOURCE ixlayer

Continue Reading

Technology

CleanSpark, Inc. Announces Closing of $2.276 Billion of Senior Secured Notes

Published

on

By

LAS VEGAS, Sept. 25, 2026 /PRNewswire/ — CleanSpark, Inc. (Nasdaq: CLSK) (“CleanSpark” or the “Company”), a market-leading data center developer, today announced that its wholly owned subsidiary, CSDC Finance I, LLC, has closed its previously announced offering of $2.276 billion aggregate principal amount of 7.875% senior secured notes due 2031.

The notes have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration. 

About CleanSpark
CleanSpark is a market-leading data center developer with a proven track record of success. We control a portfolio of more than 1.8 GW of power, land, and data centers across the United States powered by globally competitive energy prices. Sitting at the intersection of Bitcoin, energy, operational excellence, and capital

stewardship, we optimize our infrastructure to deliver superior returns to our shareholders. Monetizing low-cost, high reliability energy by producing a global emerging critical resource – compute – positions us to prosper in an ever-changing world.

Forward Looking Statements
This press release contains certain forward-looking statements within the meaning of the federal securities laws of the United States. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and is including this statement for purposes of complying with these safe harbor provisions. Any statements made in this press release that are not statements of historical fact, such as statements regarding the anticipated terms

of the notes being offered, the completion, timing and size of the proposed Offering of the notes and the intended use of the net proceeds, are forward-looking statements and should be evaluated as such. These forward-looking statements generally are identified by the words “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “seeks,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “strategy,” “future,” “forecasts,” “opportunity,” “predicts,” “potential,” “would,” “will likely result,” “continue,” and similar expressions (including the negative versions of such words or expressions).

These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by CleanSpark and our management, are inherently uncertain. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such forward looking statements. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: volatility in the price of CleanSpark’s securities due to a variety of factors, including changes in the competitive and regulated industry in which CleanSpark operates, CleanSpark’s evolving business model and strategy and efforts we may make to modify aspects of our business model or engage in various strategic initiatives, variations in performance across competitors, changes in laws and regulations affecting CleanSpark’s business, and the ability to implement business plans, forecasts, and other expectations and to identify and realize additional opportunities. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2025 filed with the Securities and Exchange Commission (“SEC”) on November 25, 2025, our Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2025 filed with the SEC on February 5, 2026, our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026 filed with the SEC on May 11, 2026, our Quarterly Report on Form 10 Q for the fiscal quarter ended June 30, 2026 filed with the SEC on August 6, 2026, and in CleanSpark’s subsequent filings with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and CleanSpark assumes no obligation and, except as required by law, does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Contacts:
Investor Relations Contact:
Kyle Sourk
702-989-7693
ir@cleanspark.com 

Media Contact:
Eleni Stylianou
702-989-7694
pr@cleanspark.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cleanspark-inc-announces-closing-of-2-276-billion-of-senior-secured-notes-302890605.html

SOURCE CleanSpark, Inc.

Continue Reading

Technology

Talent Corps Names Mark Tower as Chief Operating Officer as part of the Executive Team

Published

on

By

Talent Corps, a leading provider of skilled-trades workforce solutions, is pleased to announce the appointment of Mark Tower as Chief Operating Officer, effective October 1, 2026.

DALLAS, Sept. 25, 2026 /PRNewswire-PRWeb/ — Talent Corps, a leading provider of skilled-trades workforce solutions, is pleased to announce the appointment of Mark Tower as Chief Operating Officer, effective October 1, 2026.

Mark’s leadership experience, operational discipline, and deep understanding of the staffing industry make him the right person to help lead Talent Corps through its next stage of growth.

Tower brings more than 20 years of executive leadership experience within the staffing and human-capital management industries. Throughout his career, he has successfully led large-scale domestic and international operations, built high-performing teams, and developed growth strategies centered on operational excellence, accountability, and exceptional service. His experience includes executive oversight of a $1 billion international operation focused on connecting vocational talent with employers.

As Chief Operating Officer, Tower will oversee Talent Corps’ day-to-day operations and work closely with the company’s executive leadership team to advance its strategic priorities. His responsibilities will include strengthening operational consistency, improving collaboration across departments and markets, supporting geographic expansion, and ensuring Talent Corps continues delivering dependable workforce solutions to its clients nationwide.

Mark’s leadership experience, operational discipline, and deep understanding of the staffing industry make him the right person to help lead Talent Corps through its next stage of growth, said Jared DeRuby, Owner of Talent Corps. “He shares our commitment to our employees, skilled-trades workforce, clients, and the communities we serve. We are excited about the leadership and vision he brings to this important role.”

Tower is known for his people-focused leadership style and his ability to align teams around a clear vision. His approach combines strategic planning with hands-on operational execution, helping organizations strengthen their internal processes while remaining responsive to the evolving needs of their clients and workforce.

“I am honored to serve as Chief Operating Officer of Talent Corps,” said Tower. Talent Corps has built a strong reputation by putting people first and delivering skilled, dependable workers to our clients. “I look forward to working alongside our talented team to strengthen our operations, expand our reach, and create even greater opportunities for our employees, clients, and skilled-trades professionals.”

Tower’s appointment reflects Talent Corps’ continued investment in its leadership infrastructure and its commitment to sustainable national growth. Under his operational leadership, the company will remain focused on developing its people, improving the customer and employee experience, and connecting qualified skilled-trades professionals with meaningful opportunities across the country.

About Talent Corps

From large-scale builds to fast-moving projects, Talent Corps delivers the nationwide construction staffing solutions to keep your projects on schedule and compliant. We connect employers with reliable, safety-focused, and job-ready tradesmen across multiple industries. Whether you’re filling one position or staffing an entire project, we’ve got you covered. Learn more at talentcorps.com.

Media Contact:

Sean Dorminy

Vice President of Marketing

Talent Corps

sdorminy@talentcorps.com

214-212-6805

talentcorps.com

Media Contact

Sean Dorminy, Talent Corps, 1 214-212-6805, Marketing@talentcorps.com, https://talentcorps.com/ 

View original content to download multimedia:https://www.prweb.com/releases/talent-corps-names-mark-tower-as-chief-operating-officer-as-part-of-the-executive-team-302888926.html

SOURCE Talent Corps

Continue Reading

Technology

Notice of Data Incident

Published

on

By

BEACHWOOD, Ohio, Sept. 25, 2026 /PRNewswire/ — Saber Healthcare Group announces a security incident that may have affected certain individuals’ information. On July 27, 2026, Saber detected a service outage affecting some of its internal and external computer systems. Once discovered, Saber immediately secured and isolated its systems and began an investigation with the help of outside cybersecurity experts. The investigation determined that an outside party gained access to Saber’s corporate computer network; and on July 27, 2026 that party encrypted a small portion of files, which is what caused the outage. Saber’s electronic medical record system was hosted and maintained by a separate outside provider, whose systems were not affected by this incident. Saber’s facilities access that system over the web and there was no evidence that the medical record database was accessed, modified, or copied. Using backup copies that were not affected, they restored the inaccessible files within 24 to 48 hours of discovering the outage, with no loss of data.

Saber conducted a review of the potentially affected files to determine what information they contain. The type of information varies by individual but may include their name and one or more of the following: date of birth, driver’s license/state issued identification number, health insurance information, medical information, financial account information, passport number, and/or Social Security number. On August 19, 2026, they completed their review and began locating address information to notify individuals directly through the mail. In an abundance of caution, they are offering individuals access to credit monitoring and identity protection services at no cost.

In response to this incident, Saber took immediate steps to secure its systems and engaged third-party specialists to assist in a thorough investigation and response. They have also implemented additional security measures to further minimize the risk of a similar incident occurring in the future. Saber has not detected ongoing unauthorized activity since these additional measures were put in place. For more information or to enroll in these services, individuals should contact the organization’s assistance line at 1-833-918-1128, Monday through Friday, from 8:00 AM to 8:00 PM ET, excluding holidays.

Individuals are encouraged to remain vigilant against incidents of identity theft and fraud by reviewing credit reports/account statements and explanation of benefits forms for suspicious activity and to detect errors. Individuals may also place a fraud alert or credit freeze by contacting the credit reporting agencies: TransUnion 1-800-680-7289; Experian 1-888-397-3742; Equifax 1-888-298-0045. You can further educate yourself regarding identity theft, fraud alerts, credit freezes, and steps to protect your personal information by contacting the credit reporting bureaus, the Federal Trade Commission (“FTC”), or their state Attorney General. The FTC may be reached at 600 Pennsylvania Ave. NW, Washington, D.C. 20580; www.identitytheft.gov; 1-877-ID-THEFT (1-877-438-4338); and TTY: 1-866-653-4261. Instances of known or suspected identity theft should also be reported to law enforcement, the state Attorney General, and the FTC.

View original content:https://www.prnewswire.com/news-releases/notice-of-data-incident-302890531.html

SOURCE Saber Healthcare Group

Continue Reading

Trending